US DOE commits $400 million to boost domestic battery manufacturing, aiming to reduce reliance on foreign supply chains. Funds support projects for critical mineral processing and component production, accelerating the electric vehicle transition.
The FDA has approved a groundbreaking Alzheimer’s drug, lecanemab, shown to modestly slow cognitive decline in early-stage patients. While hailed as a crucial step, experts caution about risks of brain swelling and bleeding, emphasizing it’s not a cure but a significant new treatment option.
Vastly improved Lithium-Sulfur batteries promise to revolutionize electric vehicles and portable electronics. A new breakthrough design addresses long-standing issues of rapid degradation and low efficiency, creating a battery that charges faster, lasts longer, and holds significantly more energy.
